Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Neuroscience|January 1, 1987
Cholinergic systems influence local cerebral glucose use in specific anatomical areas: diisopropyl phosphorofluoridate versus somanL Churchill, T L Pazdernik, R S Cross, et al.
Brain Research|May 22, 1992
Patterns of glucose use after bicuculline-induced convulsions in relationship to gamma-aminobutyric acid and mu-opioid receptors in the ventral pallidum--functional markers for the ventral pallidumL Churchill, R S Cross, T L Pazdernik, et al.
Neurotoxicology|January 1, 1985
Soman-induced brain lesions demonstrated by muscarinic receptor autoradiographyL Churchill, T L Pazdernik, J L Jackson, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1984
Soman induced changes in brain regional glucose useF E Samson, T L Pazdernik, R S Cross, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 30, 1991
Serum amyloid P component in chronic renal failure and dialysisS R Nelson, G A Tennent, D Sethi, et al.
The Journal of School Health|October 1, 1985
Selecting and recruiting health programs for the School Health Education EvaluationS L Owen, M A Kirkpatrick, S W Lavery, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructureM B Pepys, T W Rademacher, S Amatayakul-Chantler, et al.
Lancet (London, England)|August 10, 1991
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P componentS R Nelson, P N Hawkins, S Richardson, et al.
Pageof 7